Pharma/Biotech Stock News: FDA Approves YERVOY (ipilimumab) for the Treatment of Patients with Newly Diagnosed or Previously-Treated Unresectable or Metastatic Melanoma, the Deadliest Form of Skin Cancer

PRINCETON, N.J. - March 28, 2011 (Investorideas.com Newswire) - Bristol-Myers Squibb Company BMY announced that the U.S. Food and Drug Administration (FDA) approved YERVOY (ipilimumab) 3 mg/kg for the treatment of patients with unresectable (inoperable) or metastatic melanoma.